Drug-drug interactions.
Preskorn
S H
SH
D015057:1-Naphthylamine / Q000031:analogs & derivatives / Q000493:pharmacokinetics / Q000494:pharmacology; D019389:Cytochrome P-450 CYP2D6; D065607:Cytochrome P-450 Enzyme Inhibitors; D003577:Cytochrome P-450 Enzyme System / Q000187:drug effects; D003866:Depressive Disorder / Q000188:drug therapy / Q000378:metabolism; D003891:Desipramine / Q000493:pharmacokinetics / Q000494:pharmacology; D004305:Dose-Response Relationship, Drug; D004347:Drug Interactions; D004359:Drug Therapy, Combination; D005473:Fluoxetine / Q000493:pharmacokinetics / Q000494:pharmacology; D006801:Humans; D006899:Mixed Function Oxygenases / Q000037:antagonists & inhibitors* / Q000187:drug effects; D017374:Paroxetine / Q000493:pharmacokinetics / Q000494:pharmacology; D012107:Research Design / Q000592:standards; D017367:Selective Serotonin Reuptake Inhibitors / Q000493:pharmacokinetics* / Q000494:pharmacology; D020280:Sertraline
D015057:1-Naphthylamine; D019389:Cytochrome P-450 CYP2D6; D065607:Cytochrome P-450 Enzyme Inhibitors; D003577:Cytochrome P-450 Enzyme System; D003891:Desipramine; D005473:Fluoxetine; D006899:Mixed Function Oxygenases; D017374:Paroxetine; D017367:Selective Serotonin Reuptake Inhibitors; D020280:Sertraline